Genelux (GNLX) Other Non-Current Assets (2022 - 2026)
Genelux (GNLX) posted Other Non-Current Assets of $144000.0 for Q1 2026, little changed on a QoQ basis from $144000.0 in Q4 2025.
Analysis
Genelux (GNLX) Other Non-Current Assets (2022 - 2026) Analysis & Trends
Genelux has reported Other Non-Current Assets for 5 years, with the latest figure at $144000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $144000.0 in Q1 2026; TTM through Mar 2026 was $144000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $144000.0, up 56.52% from the prior year.
- Other Non-Current Assets was $144000.0 for Q1 2026 at Genelux, roughly flat from $144000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.6 million in Q4 2022, with the low at $73000.0 in Q2 2025.
- Average Other Non-Current Assets over 5 years is $316454.5, with a median of $92000.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets sank 94.13% in 2023, then surged 986.96% in 2025.
- Over 5 years, Other Non-Current Assets stood at $1.6 million in 2022, then tumbled by 94.13% to $92000.0 in 2023, then changed by 0.0% to $92000.0 in 2024, then jumped by 56.52% to $144000.0 in 2025, then changed by 0.0% to $144000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $144000.0 (Q1 2026), $144000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 12.98 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 4.75 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 2.31 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 124.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 618.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 831.80 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 29.59 Mn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - | 144,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 144,000.00 |
| Dec 31, 2025 | 144,000.00 |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 73,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Dec 31, 2022 | 1.57 Mn |